BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 9637582)

  • 1. Motivation, recruitment, and screening of volunteers for a phase I/II HIV preventive vaccine trial in Thailand.
    Jenkins RA; Chinaworapong S; Morgan PA; Ruangyuttikarn C; Sontirat A; Chiu J; Michael RA; Nitayaphan S; Khamboonruang C
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):171-7. PubMed ID: 9637582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.
    Celentano DD; Beyrer C; Natpratan C; Eiumtrakul S; Sussman L; Renzullo PO; Khamboonruang C; Nelson KE
    AIDS; 1995 Sep; 9(9):1079-83. PubMed ID: 8527082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recruiting volunteers for a multisite phase I/II HIV preventive vaccine trial in Thailand.
    Thapinta D; Jenkins RA; Morgan PA; Chiu J; Boenim W; Bussaratid V; Chaddic C; Naksrisook S; Phonrat B; Sirijongdee N; Sornsathapornkul P; Sontirat A; Srisaengchai P; Suwanarach C; Wongkamhaeng S; Brown AE; Khamboonruang C; Nitayaphan S; Pitisuttithum P; Thongchareon P;
    J Acquir Immune Defic Syndr; 2002 Aug; 30(5):503-13. PubMed ID: 12154341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of a preventive HIV-1 vaccine cohort among persons attending sexually transmitted disease clinics in Thailand.
    Markowitz LE; Sirisopana N; Charonwatanachokchai A; Julvanichpong W; Siraprapasiri T; Palanuvej T; Siriwongrangsun P; Tungsakul V; Pumratana K; Chitwarakorn A; Michael RA; Brown AE
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(5):488-94. PubMed ID: 10225232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Willingness to participate in HIV-1 vaccine trials among young Thai men.
    Jenkins RA; Torugsa K; Markowitz LE; Mason CJ; Jamroentana V; Brown AE; Nitayaphan S
    Sex Transm Infect; 2000 Oct; 76(5):386-92. PubMed ID: 11141858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults-Experience from Kenya.
    Nyasani DK; Mutua GN; Sajabi RM; Ng'ang'a JW; Gachie JN; Maina AM; Lusike LL; Anzala AO; Price MA; Manyonyi GO
    PLoS One; 2018; 13(11):e0206656. PubMed ID: 30388145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Communication, recruitment and enrolment in the preventative and therapeutic phase I clinical trial against HIV/AIDS based on the recombinant HIV-1 Tat protein.
    Luzi AM; Gallo P; Colucci A; Marcotullio S; Bellino S; Longo O; Ensoli B
    AIDS Care; 2011 Aug; 23(8):939-46. PubMed ID: 21390884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial.
    O'Connell JM; Hogg RS; Chan K; Strathdee SA; McLean N; Martindale SL; Willoughby B; Remis R
    J Acquir Immune Defic Syndr; 2002 Dec; 31(5):521-8. PubMed ID: 12473841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya.
    Jackson DJ; Martin HL; Bwayo JJ; Nyange PM; Rakwar JP; Kashonga F; Mandaliya K; Ndinya-Achola JO; Kreiss JK
    AIDS; 1995 Nov; 9(11):1279-83. PubMed ID: 8561982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contextualizing willingness to participate: recommendations for engagement, recruitment & enrolment of Kenyan MSM in future HIV prevention trials.
    Doshi M; Avery L; Kaddu RP; Gichuhi M; Gakii G; du Plessis E; Dutta S; Khan S; Kimani J; Lorway RR
    BMC Public Health; 2017 May; 17(1):469. PubMed ID: 28521748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Young men who have sex with men's awareness, acceptability, and willingness to participate in HIV vaccine trials: Results from a nationwide online pilot study.
    Connochie D; Tingler RC; Bauermeister JA
    Vaccine; 2019 Oct; 37(43):6494-6499. PubMed ID: 31522806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral and social issues among volunteers in a preventive HIV vaccine trial in Thailand.
    Jenkins RA; Thapinta D; Morgan PA; Wongkamhaeng S; Sornsathapornkul P; Bussaratid V; Sontirat A; Pitisuttithum P; Thongchareoen P; Khamboonruang C; Suriyanon V; Nitayaphan S; Brown AE;
    J Acquir Immune Defic Syndr; 2005 Dec; 40(5):592-9. PubMed ID: 16284537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX B/E HIV vaccine trial, Bangkok, Thailand.
    Vanichseni S; Tappero JW; Pitisuttithum P; Kitayaporn D; Mastro TD; Vimutisunthorn E; van Griensvan F; Heyward WL; Francis DP; Choopanya K;
    AIDS; 2004 Jan; 18(2):311-6. PubMed ID: 15075550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Logics of Commitment in Vaccine Trials of the ANRS Cohorts 1992-2001.
    Fillieule O
    J Acquir Immune Defic Syndr; 2018 Oct; 79 Suppl 1():S59-S68. PubMed ID: 30222706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motivators to participation in actual HIV vaccine trials.
    Dhalla S; Poole G
    AIDS Behav; 2014 Feb; 18(2):263-77. PubMed ID: 23736885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment using respondent driven sampling, risk behaviors assessment and willingness of young female sex workers (18-25 years) in Dar Es Salaam, Tanzania to participate in HIV vaccine trials.
    Mbunda T; Tarimo EAM; Bakari M; Sandström E; Kulane A
    BMC Public Health; 2019 Nov; 19(1):1537. PubMed ID: 31796002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experiences on recruitment and retention of volunteers in the first HIV vaccine trial in Dar es Salam, Tanzania - the phase I/II HIVIS 03 trial.
    Bakari M; Munseri P; Francis J; Aris E; Moshiro C; Siyame D; Janabi M; Ngatoluwa M; Aboud S; Lyamuya E; Sandström E; Mhalu F
    BMC Public Health; 2013 Dec; 13():1149. PubMed ID: 24321091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using surrogate vaccines to assess feasibility and acceptability of future HIV vaccine trials in men: a randomised trial in inner-city Johannesburg, South Africa.
    Chimoyi L; Kamndaya M; Venables E; von Knorring N; Stadler J; MacPhail C; Chersich MF; Rees H; Delany-Moretlwe S
    BMC Public Health; 2017 Jul; 17(Suppl 3):524. PubMed ID: 28832280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors related to the willingness of young gay men to participate in preventive HIV vaccine trials.
    Hays RB; Kegeles SM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):164-71. PubMed ID: 10048904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS in Thailand: a medical student's perspective.
    Chow DC
    J Community Health; 1994 Dec; 19(6):417-31. PubMed ID: 7844247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.